GNH USA

Europe — EMA

Morniflu Adulti (Morniflumate)

GNH USA supplies Morniflu Adulti (Morniflumate), a NSAID for rheumatoid arthritis, osteoarthritis and musculoskeletal pain. Request a quote for global supply.

Request sourcing

1
Pack/s

What is Morniflumate?

Morniflumate, the active ingredient in Morniflu Adulti, is a Fenamate (NSAID) presented as a rectal formulation for rectal use. It provides anti‑inflammatory and analgesic effects for inflammatory musculoskeletal conditions in adults.

GNH USA supplies Morniflu Adulti as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Morniflumate used for?

Morniflu Adulti, a fenamate NSAID, is used to manage inflammatory conditions affecting the musculoskeletal system.

- Rheumatoid arthritis: reduces joint inflammation and pain, improving mobility. - Osteoarthritis: alleviates chronic joint discomfort and stiffness. - Acute musculoskeletal pain: provides rapid relief of pain and swelling after injury or surgery.

What are the side effects of Morniflumate?

Morniflu Adulti may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain. - Headache: mild to moderate intensity. - Dizziness: transient sensation of light‑headedness. - Skin rash: mild erythema or pruritus. - Diarrhoea: loose stools.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Renal impairment: reduced kidney function or acute renal failure. - Severe hypersensitivity reactions: anaphylaxis or Stevens‑Johnson syndrome. - Cardiovascular events: increased risk of myocardial infarction or stroke.

What precautions apply to Morniflumate?

When prescribing Morniflu Adulti, clinicians should consider several precautionary measures to minimise risk.

- Assess gastrointestinal risk: evaluate history of ulcers or bleeding before use. - Monitor liver function: perform baseline and periodic liver enzyme tests. - Evaluate renal function: check creatinine clearance, especially in elderly patients. - Use the lowest effective dose: limit duration to the shortest period required for symptom control. - Avoid in patients with known hypersensitivity to fenamates or other NSAIDs. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct heat.

What does Morniflumate interact with?

Morniflu Adulti can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other NSAIDs or corticosteroids: heightened gastrointestinal ulceration risk. - Selective serotonin reuptake inhibitors (SSRIs): amplified bleeding tendency.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal perfusion, monitor kidney function. - Diuretics: potential for reduced antihypertensive effect and renal impairment. - Lithium: NSAIDs can increase lithium serum levels, require close monitoring.

Frequently asked questions

What is Morniflu Adulti used for?+
Morniflu Adulti contains the NSAID Morniflumate and is indicated for the treatment of inflammatory musculoskeletal disorders such as rheumatoid arthritis, osteoarthritis and acute musculoskeletal pain. It helps reduce inflammation, pain and swelling associated with these conditions.
How does Morniflumate work?+
Morniflumate works by non‑selectively inhibiting the cyclooxygenase enzymes COX‑1 and COX‑2. This inhibition lowers prostaglandin production, which in turn reduces inflammation, pain and fever at the site of tissue injury.
What is the usual dose of Morniflu Adulti?+
The appropriate dose of Morniflu Adulti is determined by the prescribing healthcare professional based on the patient’s condition, severity of symptoms and individual risk factors. Patients should follow the prescriber’s instructions and not alter the dose on their own.
Is Morniflu Adulti safe during pregnancy or breastfeeding?+
Safety data for Morniflu Adulti in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by a qualified healthcare provider.
How do I order Morniflu Adulti from GNH USA?+
To order Morniflu Adulti, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Morniflu Adulti compare with other NSAIDs?+
Morniflu Adulti belongs to the fenamate subclass of NSAIDs, which share the same COX inhibition mechanism as other NSAIDs but may have a slightly different safety profile. Compared with ibuprofen or diclofenac, fenamates can be associated with a higher incidence of certain gastrointestinal effects, so individual patient factors guide the choice of agent.
How should Morniflu Adulti be stored and handled?+
Morniflu Adulti should be stored at ambient temperature, away from direct sunlight and moisture. Keep the product in its original packaging until use and protect it from excessive heat to maintain stability.
How is Morniflu Adulti administered?+
Morniflu Adulti is formulated for rectal administration. The prescribed dosage form is inserted into the rectum according to the prescriber’s instructions, allowing systemic absorption of Morniflumate.
What are the most serious risks to watch for with Morniflu Adulti?+
Serious risks include gastrointestinal ulceration or bleeding, hepatic dysfunction, renal impairment, severe hypersensitivity reactions such as anaphylaxis, and increased cardiovascular events like myocardial infarction or stroke. Patients should be monitored for these events, especially if they have pre‑existing risk factors.
Who should not use Morniflu Adulti?+
Morniflu Adulti should be avoided in individuals with known hypersensitivity to fenamates or other NSAIDs, active gastrointestinal ulceration, severe liver or kidney disease, and in patients taking anticoagulants where bleeding risk is unacceptable, unless a healthcare professional determines that benefits outweigh risks.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Morniflumate
Route
Rectal Use
Manufacturer
Master Pharma S.R.L.
Origin
EU

Related products